Overview on Remdesivir
Journal: International Journal of Science and Research (IJSR) (Vol.10, No. 6)Publication Date: 2021-06-05
Authors : Sahil Surendrakumar Shambharkar;
Page : 1344-1349
Keywords : remdesivir; GS-441524; SARS-COV-2; COVID-19; nucleoside triphosphate; RNA dependant RNA polymerase; ebola;
Abstract
Remdesiviris a broad range anti viral drug primarily discovered for the treatment for hepatitis C and respiratory syncytial virus (RSV), later used in the treatment of ebola and now is being used in the treatment of covid-spectrum antiviral agent that has previously demonstrated antiviral activity against filoviruses (ebola viruses, marburgvirus), coronaviruses (SARS-COV, MERS-CO-V, SARS-COV-2), paramyxoviruses (parainfluenza type iii virus, nipah virus, hendra virus, measles, and mumps virus), and pnemoviridae (respiratory syncytial virus).
Other Latest Articles
- Mashaknashak Yog in Mashak
- Comparative Study of Efficacy of Epley's and Semont?s Maneuver in the Treatment of Benign Paroxysmal Positional Vertigo in a Tertiary Hospital
- Digital Identity: The Influence of Digitalization and New Technologies on the Challenge of Balancing the Anti-Financial Crimes Program and Customer Satisfaction in Banking Institutions
- Mashak Conceptual Study
- Evaluation of the Carrying Angle of the Elbow Joint in Adolescents and its Correlation with BMI, Gender and Dominant Side
Last modified: 2021-07-05 13:46:22